Soham D Puvvada

  • 1440 Citations
  • 13 h-Index
20102018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Soham D Puvvada is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Non-Hodgkin's Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Hemophagocytic Lymphohistiocytosis Medicine & Life Sciences
Vincristine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2018

  • 1440 Citations
  • 13 h-Index
  • 26 Article
  • 3 Review article
  • 1 Comment/debate
2 Citations (Scopus)

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Kelly, K. R., Friedberg, J. W., Park, S. I., McDonagh, K., Hayslip, J., Persky, D., Ruan, J., Puvvada, S. D., Rosen, P., Iyer, S. P., Stefanovic, A., Bernstein, S. H., Weitman, S., Karnad, A., Monohan, G., VanderWalde, A., Mena, R., Schmelz, M., Perry, C. S., Groshen, S. & 5 others, Venkatakrishnan, K., Zhou, X., Sheldon-Waniga, E., Jane Leonard, E. & Mahadevan, D., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6150-6159 10 p.

Research output: Contribution to journalArticle

Aurora Kinase A
Vincristine
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, Large B-Cell, Diffuse
2 Citations (Scopus)

Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study

Puvvada, S. D., Guillén-Rodríguez, J. M., Yan, J., Inclán, L., Heard, K., Rivera, X. I., Anwer, F. ., Mahadevan, D., Schatz, J. H. & Persky, D. O., Feb 22 2018, (Accepted/In press) In : Oncology (Switzerland).

Research output: Contribution to journalArticle

Radioimmunotherapy
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Disease-Free Survival
Drug Therapy
4 Citations (Scopus)

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

Kendrick, S., Rimsza, L. M., Scott, D. W., Slack, G. W., Farinha, P., Tan, K. L., Persky, D., Puvvada, S. D., Connors, J. M., Sehn, L., Gascoyne, R. D. & Schmelz, M., Jan 1 2017, In : Virchows Archiv. 470, 1, p. 113-117 5 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: A systematic review and meta-analysis

Riaz, I. B., Zahid, U., Kamal, M. U., Husnain, M., McBride, A., Hua, A., Hamadani, A. A., George, L., Zeeshan, A., Sipra, Q. U. A. R., Raina, A., Rahman, B., Puvvada, S. D. & Anwer, F. ., Sep 1 2017, In : Immunotherapy. 9, 12, p. 979-993 15 p.

Research output: Contribution to journalReview article

Meta-Analysis
B-Lymphocytes
Hematologic Neoplasms
T-Lymphocytes
Neurotoxicity Syndromes
4 Citations (Scopus)

A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma

Puvvada, S. D., Guillén-Rodríguez, J. M., Rivera, X. I., Heard, K., Inclan, L., Schmelz, M., Schatz, J. H. & Persky, D. O., Sep 5 2017, (Accepted/In press) In : Oncology (Switzerland).

Research output: Contribution to journalArticle

Lymphoma
Lymphoma, Large B-Cell, Diffuse
Major Histocompatibility Complex
Biomarkers
Histone Deacetylases